Latest filing published 23 Nov 2017 for Acasti Pharma Inc..
This profile gathers the share dealings of Jean-Daniel Bélanger in Acasti Pharma Inc. Between 24 February 2017 and 20 November 2017, the trades on record add up to 4 filings.
No open-market purchase appears, only 2 sales worth €92k.
On 23 November 2017 came the latest disclosure, a transaction in Acasti Pharma Inc. The median gap between a trade and its publication by SEDI is 4 days. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations